Experts' Perspectives: Top Stories in Cardiology for 2024

As the medical community turns the page on 2024 and enters a new chapter in the coming year, few fields have as much reason to celebrate the outgoing year as cardiology.

A year marked by historic discoveries and regulatory approvals, a bevy of subspecialties welcomed practice-changing, outcome-altering updates—from obesity care to amyloidosis, artificial intelligence, heart failure, and a slew of other areas.

To celebrate the news that defined the past year in cardiovascular medicine, the editorial team of HCPLive Cardiology has compiled responses from leading subject matter experts recorded during the American Heart Association (AHA) Scientific Sessions 2024and the 22nd Annual World Congress Insulin Resistance Diabetes & Cardiovascular Disease (WCIRDC) as part of HCPLive’s This Year in Medicine series.

Below is a list and brief description of the 8 experts featured in our video.

Our Experts

• Muthiah Vaduganathan, MD, MPH, codirector of the Center for Cardiometabolic Implementation Science of Brigham and Women’s Hospital and host of the Don’t Miss a Beat podcast
• Viet Le, PA-C, DMSc, an associate professor of research and a preventive cardiology PA at Intermountain Health. Le is also the immediate past president of the Academy of Physician Associates in Cardiology and a member of the HCPLive Editorial Advisory Board
• Erin Michos, MD, director of women's cardiovascular health and the associate director of preventive cardiology within the Johns Hopkins Ciccarone Center for the Prevention of Cardiovascular Disease
• Matthew Budoff, MD, a professor of medicine at the David Geffen School of Medicine at UCLA and an investigator at The Lundquist Institute
• Orly Vardeny, PharmD, MS, associate professor of medicine at the Minneapolis VA Health Care System and University of Minnesota
• Stephen Nicholls, MBBS, PhD, director of the Victorian Heart Hospital and Institute and professor of cardiology at Monash University
• Ahmad Masri, MD, MS, director of the Hypertrophic Cardiomyopathy Center at Oregon Health and Science University
• Michael Weber, MD, professor of Medicine in the Division of Cardiovascular Medicine of the State University of New York